Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
PainPeripheral Neuropathy
Interventions
BEHAVIORAL

EEG biofeedback (BF) Group

Group 1 will take part in a minimum of 2 neurofeedback training sessions each week for up to 10 weeks, for a total of up to 20 training sessions.

BEHAVIORAL

Wait-List Control (WLC) Group

Group 2 will be placed on a wait-list, will continue to receive standard care, will not take part in the neurofeedback training, but will take part in the follow-up visits.

BEHAVIORAL

Follow UP Questionnaires

After Group 1 completes neurofeedback training, both Groups to complete 10 questionnaires that were completed at baseline.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01278225 - Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain | Biotech Hunter | Biotech Hunter